Safety of a New Subcutaneous Testosterone Enanthate Auto-Injector: Results of a 26-Week Study.
Saved in:
| Title: | Safety of a New Subcutaneous Testosterone Enanthate Auto-Injector: Results of a 26-Week Study. |
|---|---|
| Authors: | Gittelman M; Uromedix, Aventura, FL, USA., Jaffe JS; Antares Pharma, Inc., Ewing, NJ, USA. Electronic address: jjaffe@antarespharma.com., Kaminetsky JC; Manhattan Medical Research, New York, NY, USA. |
| Source: | The journal of sexual medicine [J Sex Med] 2019 Nov; Vol. 16 (11), pp. 1741-1748. Date of Electronic Publication: 2019 Sep 21. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: Netherlands NLM ID: 101230693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1743-6109 (Electronic) Linking ISSN: 17436095 NLM ISO Abbreviation: J Sex Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
